Labviva announces the general availability of its automated Inventory Management System (IMS), a core feature of Labviva’s software-as-a-service (SaaS) platform. The IMS enables laboratory scientists, researchers and procurement professionals at the nation's top pharmaceutical companies and universities to work in real time by streamlining inventory management of external suppliers and internal supplies of a shared organizational inventory or stock room.
Labviva’s IMS offers customers extensive automation capabilities across the platform, in addition to a highly intuitive user interface (UI), customizable inventory workflows, and actionable access to stock data. Currently, several top global pharmaceutical companies already use Labviva’s IMS to drive efficiencies, accelerate research and realize significant cost savings across the life sciences procurement process.
“Labviva is experiencing hypergrowth and reaching an inflection point as it cements its position as the trusted brand in life sciences,” says Kleida Martiro, partner at Glasswing Ventures and Labviva investor and board observer. “Using its AI-first platform and automated approach to delivering supply chain transparency, the company is transforming the way laboratories manage supply chain tracking and replenishment.”
Key Takeaways:
- Labviva’s advanced IMS benefits the entire laboratory research organization. Scientists can locate and review stock items while simultaneously accessing their compliance and research data. Research teams can review and share content about environmental health and safety (EHS), chemical classification and master data enrichment. Lab managers can track shipments, access AI-driven operational recommendations across 15 million SKUs and 8,000 manufacturers and increase efficiencies using AI-driven replenishment. Procurement teams can use Labviva’s IMS technology to optimize forecasting, reporting, purchasing and resource planning.
